Extending the spectrum of precompetitive collaboration in oncology research workshop summary
"Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, D.C.
National Academies Press
2010, c2010
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Introduction
- Current driving forces for collaboration
- Benefits of collaborating
- Challenges to collaborating
- What to share
- Types of precompetitive collaborations
- Lessons learned
- Next steps
- Summary
- Includes bibliographical references (p. 80-83)